For example, in patients deficient in FVIII (i.e., with hemophilia A), therapy to treat or prevent bleeding may include the replacement of FVIII, or use of FVIII bypassing therapy, or other means to rebalance hemostasis [10]. The gene discussed is F8; the disease is hemophilia A.